Chan Kyo Kim1, Sung Yoon Park, Byung Kwan Park, Won Park, Seung Jae Huh. 1. Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Gangnam-gu, Seoul, Republic of Korea.
Abstract
OBJECTIVES: To investigate the value of blood oxygenation level-dependent (BOLD) magnetic resonance imaging (MRI) as a predictor of therapeutic response in cervical cancer patients undergoing concurrent chemoradiotherapy (CCRT). METHODS: Thirty consecutive patients with biopsy-proven cervical cancer were examined by BOLD MRI before (preTx) and after CCRT (postTx). The R2* value (s(-1)) was calculated in the tumour and normal myometrium for preTx and postTx studies. Final tumour responses, as determined by changes of tumour size or volume on MRI, were correlated with tumour R2* values at preTx. RESULTS: The mean R2* values of tumours at preTx (21.1) were significantly lower than those at postTx (39.4 s(-1)) (p < 0.001), while those of normal myometrium were similar between preTx and postTx (p = 0.363). At preTx, tumour R2* values showed significantly negative correlation with final tumour size response (p = 0.022, Spearman's coefficient = -0.415). However, tumour R2* values at preTx were not associated with final tumour volume response (p = 0.069). CONCLUSIONS: BOLD MRI at 3 T, as an imaging biomarker, may have the potential to evaluate therapeutic response in cervical cancers. The association between BOLD MRI findings and CCRT responses warrants further validation. KEY POINTS: • Hypoxia in cervical cancer is an independent risk factor • BOLD MRI reflect oxygenation status of tissue adjacent to perfused microvessels • Pretreatment tumour R2* reveal negative correlation with final tumour size response • Accurate oxygenation assessment in cervical cancer may help clinical decision making.
OBJECTIVES: To investigate the value of blood oxygenation level-dependent (BOLD) magnetic resonance imaging (MRI) as a predictor of therapeutic response in cervical cancerpatients undergoing concurrent chemoradiotherapy (CCRT). METHODS: Thirty consecutive patients with biopsy-proven cervical cancer were examined by BOLD MRI before (preTx) and after CCRT (postTx). The R2* value (s(-1)) was calculated in the tumour and normal myometrium for preTx and postTx studies. Final tumour responses, as determined by changes of tumour size or volume on MRI, were correlated with tumour R2* values at preTx. RESULTS: The mean R2* values of tumours at preTx (21.1) were significantly lower than those at postTx (39.4 s(-1)) (p < 0.001), while those of normal myometrium were similar between preTx and postTx (p = 0.363). At preTx, tumour R2* values showed significantly negative correlation with final tumour size response (p = 0.022, Spearman's coefficient = -0.415). However, tumour R2* values at preTx were not associated with final tumour volume response (p = 0.069). CONCLUSIONS: BOLD MRI at 3 T, as an imaging biomarker, may have the potential to evaluate therapeutic response in cervical cancers. The association between BOLD MRI findings and CCRT responses warrants further validation. KEY POINTS: • Hypoxia in cervical cancer is an independent risk factor • BOLD MRI reflect oxygenation status of tissue adjacent to perfused microvessels • Pretreatment tumour R2* reveal negative correlation with final tumour size response • Accurate oxygenation assessment in cervical cancer may help clinical decision making.
Authors: H C Wagenaar; J B Trimbos; S Postema; A Anastasopoulou; R J van der Geest; J H Reiber; G G Kenter; A A Peters; P M Pattynama Journal: Gynecol Oncol Date: 2001-09 Impact factor: 5.482
Authors: Joseph Waller; Benjamin Onderdonk; Ann Flood; Harold Swartz; Jaffer Shah; Asghar Shah; Bulent Aydogan; Howard Halpern; Yasmin Hasan Journal: Br J Radiol Date: 2020-04-22 Impact factor: 3.039
Authors: Christopher N Rumley; Mark T Lee; Lois Holloway; Robba Rai; Myo Min; Dion Forstner; Allan Fowler; Gary Liney Journal: BMC Cancer Date: 2017-07-10 Impact factor: 4.430
Authors: Jonathan P May; Eno Hysi; Lauren A Wirtzfeld; Elijus Undzys; Shyh-Dar Li; Michael C Kolios Journal: PLoS One Date: 2016-10-27 Impact factor: 3.240
Authors: Abhishek Mahajan; Reena Engineer; Supriya Chopra; Umesh Mahanshetty; S L Juvekar; S K Shrivastava; Naresh Desekar; M H Thakur Journal: Eur J Radiol Open Date: 2015-12-12